Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research.
about
Alcohol Withdrawal Syndrome: Benzodiazepines and BeyondIs it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature.Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.Severe alcohol withdrawal syndrome: Evolution of care and impact of adjunctive therapy on course and complications of 171 intensive care unit patients.
P2860
Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Dexmedetomidine for the treatm ...... nd current status of research.
@en
type
label
Dexmedetomidine for the treatm ...... nd current status of research.
@en
prefLabel
Dexmedetomidine for the treatm ...... nd current status of research.
@en
P2093
P2860
P1433
P1476
Dexmedetomidine for the treatm ...... nd current status of research.
@en
P2093
Andrew J Muzyk
Jane P Gagliardi
Scott Brudney
Suzanne Kerns
P2860
P2888
P304
P356
10.1007/S40263-013-0106-6
P577
2013-11-01T00:00:00Z